Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes

Abstract Background Systemic inflammatory processes plausibly contribute to the development of cardiovascular complications, causing increased morbidity and mortality in type 2 diabetes. Circulating inflammatory markers, i.e., interleukin (IL)-6 and tumour necrosis factor-α, are associated with neur...

Full description

Bibliographic Details
Main Authors: A. M. Wegeberg, T. Okdahl, S. Riahi, N. Ejskjaer, F. Pociot, J. Størling, B. Brock, C. Brock
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Cardiovascular Diabetology
Subjects:
Online Access:https://doi.org/10.1186/s12933-021-01437-w
_version_ 1819229347001663488
author A. M. Wegeberg
T. Okdahl
S. Riahi
N. Ejskjaer
F. Pociot
J. Størling
B. Brock
C. Brock
author_facet A. M. Wegeberg
T. Okdahl
S. Riahi
N. Ejskjaer
F. Pociot
J. Størling
B. Brock
C. Brock
author_sort A. M. Wegeberg
collection DOAJ
description Abstract Background Systemic inflammatory processes plausibly contribute to the development of cardiovascular complications, causing increased morbidity and mortality in type 2 diabetes. Circulating inflammatory markers, i.e., interleukin (IL)-6 and tumour necrosis factor-α, are associated with neurocardiac measures. We examined a broad panel of various inflammatory and inflammation-related serum markers to obtain more detailed insight into the possible neuro-immune interaction between cardiovascular regulation and systemic level of inflammation. Methods Serum samples from 100 participants with type 2 diabetes were analysed. Heart rate variability, cardiovascular autonomic reflex tests, and cardiac vagal tone tests were performed based on electrocardiographic readings. Data regarding covariates (demographic-, diabetes-, and cardiovascular risk factors) were registered. Results Increased serum levels of IL-12/IL-23p40 (p  < 0.01) and intercellular adhesion molecule (ICAM)-1 (p  < 0.007) were associated with diminished heart rate variability measures. After all adjustments, the associations between IL-12/23p40, SDANN and VLF persisted (p  = 0.001). Additionally, serum levels of vascular endothelial growth factor (VEGF)-C were associated with response to standing (p  = 0.005). Discussion The few but robust associations between neurocardiac regulation and serum markers found in this study suggest systemic changes in proinflammatory, endothelial, and lymphatic function, which collectively impacts the systemic cardiovascular function. Our results warrant further exploration of IL-12/IL-23p40, ICAM-1, and VEGF-C as possible cardiovascular biomarkers in T2D that may support future decisions regarding treatment strategies for improved patient care.
first_indexed 2024-12-23T11:11:43Z
format Article
id doaj.art-d101180051e14249b03007d6b9305f1b
institution Directory Open Access Journal
issn 1475-2840
language English
last_indexed 2024-12-23T11:11:43Z
publishDate 2022-01-01
publisher BMC
record_format Article
series Cardiovascular Diabetology
spelling doaj.art-d101180051e14249b03007d6b9305f1b2022-12-21T17:49:20ZengBMCCardiovascular Diabetology1475-28402022-01-0121111010.1186/s12933-021-01437-wElevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetesA. M. Wegeberg0T. Okdahl1S. Riahi2N. Ejskjaer3F. Pociot4J. Størling5B. Brock6C. Brock7Mech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital and Clinical Institute, Aalborg UniversityMech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital and Clinical Institute, Aalborg UniversityDepartment of Cardiology, Aalborg University HospitalSteno Diabetes Center North Denmark, Aalborg University HospitalSteno Diabetes Center CopenhagenSteno Diabetes Center CopenhagenSteno Diabetes Center CopenhagenMech-Sense, Department of Gastroenterology and Hepatology, Aalborg University Hospital and Clinical Institute, Aalborg UniversityAbstract Background Systemic inflammatory processes plausibly contribute to the development of cardiovascular complications, causing increased morbidity and mortality in type 2 diabetes. Circulating inflammatory markers, i.e., interleukin (IL)-6 and tumour necrosis factor-α, are associated with neurocardiac measures. We examined a broad panel of various inflammatory and inflammation-related serum markers to obtain more detailed insight into the possible neuro-immune interaction between cardiovascular regulation and systemic level of inflammation. Methods Serum samples from 100 participants with type 2 diabetes were analysed. Heart rate variability, cardiovascular autonomic reflex tests, and cardiac vagal tone tests were performed based on electrocardiographic readings. Data regarding covariates (demographic-, diabetes-, and cardiovascular risk factors) were registered. Results Increased serum levels of IL-12/IL-23p40 (p  < 0.01) and intercellular adhesion molecule (ICAM)-1 (p  < 0.007) were associated with diminished heart rate variability measures. After all adjustments, the associations between IL-12/23p40, SDANN and VLF persisted (p  = 0.001). Additionally, serum levels of vascular endothelial growth factor (VEGF)-C were associated with response to standing (p  = 0.005). Discussion The few but robust associations between neurocardiac regulation and serum markers found in this study suggest systemic changes in proinflammatory, endothelial, and lymphatic function, which collectively impacts the systemic cardiovascular function. Our results warrant further exploration of IL-12/IL-23p40, ICAM-1, and VEGF-C as possible cardiovascular biomarkers in T2D that may support future decisions regarding treatment strategies for improved patient care.https://doi.org/10.1186/s12933-021-01437-wDiabetes mellitus, type 2Cardiovascular diseasesInflammation
spellingShingle A. M. Wegeberg
T. Okdahl
S. Riahi
N. Ejskjaer
F. Pociot
J. Størling
B. Brock
C. Brock
Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
Cardiovascular Diabetology
Diabetes mellitus, type 2
Cardiovascular diseases
Inflammation
title Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
title_full Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
title_fullStr Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
title_full_unstemmed Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
title_short Elevated levels of interleukin-12/23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
title_sort elevated levels of interleukin 12 23p40 may serve as a potential indicator of dysfunctional heart rate variability in type 2 diabetes
topic Diabetes mellitus, type 2
Cardiovascular diseases
Inflammation
url https://doi.org/10.1186/s12933-021-01437-w
work_keys_str_mv AT amwegeberg elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT tokdahl elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT sriahi elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT nejskjaer elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT fpociot elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT jstørling elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT bbrock elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes
AT cbrock elevatedlevelsofinterleukin1223p40mayserveasapotentialindicatorofdysfunctionalheartratevariabilityintype2diabetes